Z

Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456

Watchlist Manager
Zhejiang Jiuzhou Pharmaceutical Co Ltd
SSE:603456
Watchlist
Price: 14.87 CNY -5.41% Market Closed
Market Cap: 13.4B CNY
Have any thoughts about
Zhejiang Jiuzhou Pharmaceutical Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

12
Current
22
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
12
=
Enterprise Value
11.2B CNY
/
EBIT
938.6m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
8.1
2-Years Forward
EV/EBIT
6.8
3-Years Forward
EV/EBIT
6

See Also

Discover More